| 产品详情 |
| Edit |   |
| Product Name | Tideglusib |
| Description | Purity >98%. Tideglusib is a thiadiazolidinone that prevents inflammation and neurodegeneration when injected into rat hippocampus concurrently with kainic acid, a compound that causes excitotoxicity. Tideglusib-induced neuroprotection, in this model, is attenuated by the PPARGamma antagonist GW9662 . Interestingly, tideglusib also irreversibly inhibits glycogen synthase kinase-3Beta (GSK3Beta) with an IC50 value of 5 nM when used with a one hour preincubation, increasing to 0.1-1 µM without preincubation. Several GSK3 inhibitors, including tideglusib, promote hippocampal neurogenesis both in vitro and in vivo, suggesting suitability in Alzheimer's therapy. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 2-(1-naphthalenyl)-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione, NP031112 |
| Gene, Accession, CAS # | CAS: 865854-05-3 |
| Catalog # | LS-H10220 |
| Price | |
| Order / More Info | Tideglusib from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|